Author

Andrew Hartley

Cancer Research UK Scotland InstituteORCID 0000-0002-9536-7846Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Amy J. TibboiD· 1 shared Hing Y. LeungiD· 1 shared Imran AhmadiD· 1 shared Karen BlythiD· 1 shared Laura C.A. GalbraithiD· 1 shared Laura WilsoniD· 1 shared Rajan Veeratterapillay· 1 shared Rakesh HeeriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amy J. TibboORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Loss of ARID1A accelerates prostate tumourigenesis with a proliferative collagen-poor phenotype through co-operation with AP1 subunit cFos

Andrew Hartley, Laura C.A. Galbraith, Robin Shaw, Amy J. Tibbo, Rajan Veeratterapillay, Laura Wilson, Rakesh Heer, Karen Blyth, Hing Y. Leung, Imran Ahmad

This study identifies Arid1a loss as a driver of aggressive prostate cancer in mice, accelerating tumorigenesis and promoting a proliferative, collagen-poor phenotype through cooperation with cFos.

British Journal of Cancer · Jan 30, 2025Peer-reviewedCancer Biology